Video Latest - ecancer

Cancer or amyloidosis?

Dr Giovanni Palladini - Director, Amyloidosis Research and Treatment Center, Pavia, Italy

2 Nov 2016

Monoclonal antibodies in multiple myeloma

Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France

1 Nov 2016

How can we make the best decisions for health whilst considering cost?

Dr Andrea Manca - University of York, York, UK

1 Nov 2016

Preemptively treating patients most at risk of progression to myeloma

Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain

1 Nov 2016

Drug combos with daratumumab likely to become standard of care in myeloma

Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland

1 Nov 2016

Overview of the CD38 antibody in multiple myeloma

Dr Torben Plesner - Vejle Hospital, Vejle, Denmark

1 Nov 2016

New drugs and combinations in haematological cancers improve complete remission rates

Dr Paolo Corradini - University of Milan, Milan, Italy

1 Nov 2016

Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment

Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany

1 Nov 2016

Editor's Choice for October 2016

Prof Gordon McVie - Editor in Chief, ecancer

1 Nov 2016

What does the Association of European Cancer Leagues (ECL) do?

Dr Wendy Yared - Director, Association of European Cancer Leagues (ECL)

26 Oct 2016

Coming of age for CDK 4/6 inhibitors: Welcome and interactive session

Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy

26 Oct 2016

What are CDKs?

Dr Ghadeer Shubassi - FIRC Institute of Molecular Oncology (IFOM), Milan, Italy

26 Oct 2016

Video